Quantum Genomics Société Anonyme (ALQGC.PA)
EUR 0.07
(0.0%)
EUR 0.07
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -20.21 Million | -17.01 Million | -11.99 Million | -10.42 Million | -10.9 Million |
| Net Income | -3.17 Million | -24.93 Million | -17.35 Million | -16.22 Million | -9.88 Million | -11.99 Million |
| Depreciation & Amortization | - | 263.77 Thousand | 390 Thousand | 137 Thousand | 153 Thousand | 19.01 Thousand |
| Deferred income taxes | - | - | -818 Thousand | -635 Thousand | 517 Thousand | - |
| Stock-based compensation | - | - | 1.56 Million | 1.48 Million | 859 Thousand | - |
| Change in working capital | - | 59.82 Thousand | -1.56 Million | 1.09 Million | -1.37 Million | -178 Thousand |
| Other non-cash items | 3.17 Million | 4.39 Million | 769 Thousand | 2.15 Million | -695 Thousand | 1.24 Million |
| Investing Cash Flow | - | -152.53 Thousand | -45 Thousand | -411 Thousand | -116 Thousand | -231 Thousand |
| Investments in PPE | - | - | -45 Thousand | -411 Thousand | -116 Thousand | -16 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -32.53 Thousand | - | - | - | -215 Thousand |
| Sales/Maturities of investments | - | - | - | - | 105 Thousand | - |
| Other Investing Activities | - | -120 Thousand | - | 6000.00 | -105 Thousand | -215 Thousand |
| Financing Cash Flow | - | 17.21 Million | 3.46 Million | 28.38 Million | 6.91 Million | 14.84 Million |
| Debt repayment | - | -31.62 Thousand | -2.75 Million | -27 Thousand | -462 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 17.18 Million | 846 Thousand | 28.5 Million | 7.38 Million | 15.07 Million |
| Other Financing Activities | - | 31.62 Thousand | -1000.00 | -87 Thousand | -8000.00 | -231 Thousand |
| Accounts receivables | - | 59.82 Thousand | 763 Thousand | -823 Thousand | -223 Thousand | - |
| Accounts payables | - | - | 767 Thousand | 1.94 Million | -1.36 Million | 1.41 Million |
| Inventory | - | - | - | -1.41 Million | 89 Thousand | -178 Thousand |
| Other working capital | - | -4.99 Million | -3.09 Million | 1.38 Million | -1.46 Million | -313 Thousand |
| Cash at beginning of period | 10.4 Million | 13.55 Million | 27.15 Million | 2.19 Million | 14.79 Million | 11.08 Million |
| Cash at end of period | 10.4 Million | 10.4 Million | 13.55 Million | 27.15 Million | 11.16 Million | 14.79 Million |
| Capital Expenditure | - | - | -45 Thousand | -411 Thousand | -116 Thousand | -16 Thousand |
| Effect of forex changes on cash | - | 55.00 | - | 6000.00 | - | - |
| Net cash flow / Change in cash | - | -3.15 Million | -13.6 Million | 24.95 Million | -3.63 Million | 3.7 Million |
| Free Cash Flow | - | -20.21 Million | -17.06 Million | -12.4 Million | -10.54 Million | -10.91 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.18 Million | -3.17 Million | -1.98 Million | -16.08 Million | -24.93 Million | -11.95 Million |
| Depreciation & Amortization | - | - | 4476.00 | 67.77 Thousand | 263.77 Thousand | 196 Thousand |
| Deferred income taxes | - | - | - | -11.82 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 9.82 Million | -5.71 Million | 59.82 Thousand | -131 Thousand |
| Other non-cash items | 1.18 Million | 3.17 Million | -15.48 Million | 12.61 Million | 4.39 Million | 2.6 Million |
| Investing Cash Flow | - | - | -6811.00 | -149.53 Thousand | -152.53 Thousand | -3000.00 |
| Investments in PPE | - | - | - | 3000.00 | - | -3000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -32.53 Thousand | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -6811.00 | -152.53 Thousand | -120 Thousand | - |
| Financing Cash Flow | - | - | - | 219.98 Thousand | 17.21 Million | 16.99 Million |
| Debt repayment | - | - | - | - | -31.62 Thousand | -48 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 17.18 Million | 17.11 Million |
| Other Financing Activities | - | - | - | 219.98 Thousand | 31.62 Thousand | 17.1 Million |
| Accounts receivables | - | - | - | 568.82 Thousand | 59.82 Thousand | -509 Thousand |
| Accounts payables | - | - | - | - | - | -909 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 9.82 Million | -6.28 Million | -4.99 Million | 1.28 Million |
| Cash at beginning of period | 2.75 Million | 10.4 Million | 10.39 Million | 19.44 Million | 13.55 Million | 24.87 Million |
| Cash at end of period | 2.75 Million | 10.4 Million | 2.75 Million | - | 10.4 Million | 19.44 Million |
| Capital Expenditure | - | - | - | 3000.00 | - | -3000.00 |
| Effect of forex changes on cash | - | - | - | -10.39 Million | 55.00 | 13.55 Million |
| Net cash flow / Change in cash | - | - | -7.64 Million | -19.44 Million | -3.15 Million | -5.42 Million |
| Free Cash Flow | - | - | -7.63 Million | -9.11 Million | -20.21 Million | -11.09 Million |
RROYF
BTE
ECOB
0RPY
RAND
DGA